{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:17:49Z","timestamp":1761527869836,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003335","name":"Ministry of Education, Youth and Science","doi-asserted-by":"publisher","award":["1M6798582302"],"award-info":[{"award-number":["1M6798582302"]}],"id":[{"id":"10.13039\/501100003335","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["433\/14-1,14-2"],"award-info":[{"award-number":["433\/14-1,14-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.vph.2007.04.005","type":"journal-article","created":{"date-parts":[[2007,4,22]],"date-time":"2007-04-22T07:09:32Z","timestamp":1177225772000},"page":"63-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["AT1 receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats"],"prefix":"10.1016","volume":"47","author":[{"given":"Ivana","family":"Van\u011b\u010dkov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libor","family":"Kopkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Huskov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdenka","family":"Va\u0148ourkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislava","family":"Schejbalov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lud\u011bk","family":"\u010cervenka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert J.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2007.04.005_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/hy09t1.095207","article-title":"Angiotensin II AT(1A) receptor antisense lowers blood pressure in acute 2-kidney, 1-clip hypertension","volume":"38","author":"Galli","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2007.04.005_bib2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0895-7061(97)00076-9","article-title":"Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT1 angiotensin receptor mRNA in spontaneously hypertensive rats","volume":"10","author":"Gyurko","year":"1997","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.vph.2007.04.005_bib3","doi-asserted-by":"crossref","first-page":"9960","DOI":"10.1073\/pnas.93.18.9960","article-title":"Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense","volume":"93","author":"Iyer","year":"1996","journal-title":"PNAS"},{"key":"10.1016\/j.vph.2007.04.005_bib4","first-page":"H1260","article-title":"Reversal of hypertension by angiotensin II type 1 receptor antisense gene therapy in the adult SHR","volume":"277","author":"Katovich","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2007.04.005_bib5","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/01.hjh.0000174972.46663.5e","article-title":"The role of intrarenal angiotensin II in the development of hypertension in Ren-2 transgenic rats","volume":"23","author":"Kopkan","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2007.04.005_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1042\/CS20050271","article-title":"Developmental windows and environment as important factors in the expression of genetic information: a cardiovascular physiologist's view","volume":"111","author":"Kune\u0161","year":"2006","journal-title":"Clin. Sci."},{"key":"10.1016\/j.vph.2007.04.005_bib7","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.gt.3302838","article-title":"Gene therapy progress and prospects: non-vira\u016f gene therapy by systemic delivery","volume":"13","author":"Li","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.vph.2007.04.005_bib8","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1161\/01.HYP.31.5.1166","article-title":"Intravenous injection with antisense oligodeoxynucleotides against angiotensinogen decreases blood pressure in spontaneously hypertensive rats","volume":"31","author":"Makino","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2007.04.005_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.molmed.2005.03.008","article-title":"Genetic therapies for cardiovascular diseases","volume":"11","author":"Melo","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.vph.2007.04.005_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/344541a0","article-title":"Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene","volume":"344","author":"Mullins","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.vph.2007.04.005_bib11","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.gt.3301923","article-title":"Gene therapy and prospects: nonviral vectors","volume":"9","author":"Niidome","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.vph.2007.04.005_bib12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.HYP.0000017827.63253.16","article-title":"Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy","volume":"39","author":"Pachori","year":"2002","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.vph.2007.04.005_bib13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of the local renin-angiotensin system","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2007.04.005_bib14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/01.HYP.31.6.1317","article-title":"Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood","volume":"31","author":"Peng","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2007.04.005_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/01.HYP.25.3.314","article-title":"Antisense inhibition of hypertension in the spontaneously hypertensive rat","volume":"25","author":"Wielbo","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.vph.2007.04.005_bib16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1152\/physrev.1999.79.4.1227","article-title":"Ontogenetic aspects of hypertension development: analysis in the rat","volume":"79","author":"Zicha","year":"1999","journal-title":"Physiol. Rev."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189107000742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189107000742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T01:15:51Z","timestamp":1761527751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189107000742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S1537189107000742"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2007.04.005","relation":{},"ISSN":["1537-1891"],"issn-type":[{"type":"print","value":"1537-1891"}],"subject":[],"published":{"date-parts":[[2007,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AT1 receptor antisense therapy transiently lowers blood pressure in Ren-2 transgenic rats","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2007.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}